165 related articles for article (PubMed ID: 31400763)
1. Histopathological Changes of Organs (Lungs, Liver, Kidney, and Brain) After Using Two Types of AgiCoat and Acticoat Nanosilver Dressings on Deep Second-Degree Burn in Rat.
Karimi H; Latifi NA; Mehrjerdi AZ; Jafarnejad B; Karimi AM
J Burn Care Res; 2020 Jan; 41(1):141-150. PubMed ID: 31400763
[TBL] [Abstract][Full Text] [Related]
2. A silver-coated antimicrobial barrier dressing used postoperatively on meshed autografts: a dressing comparison study.
Silver GM; Robertson SW; Halerz MM; Conrad P; Supple KG; Gamelli RL
J Burn Care Res; 2007; 28(5):715-9. PubMed ID: 17667837
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of three silver dressings in an infected animal model.
Heggers J; Goodheart RE; Washington J; McCoy L; Carino E; Dang T; Edgar P; Maness C; Chinkes D
J Burn Care Rehabil; 2005; 26(1):53-6. PubMed ID: 15640735
[TBL] [Abstract][Full Text] [Related]
4. Toxicity assessment of nanosilver wound dressing in Wistar rat.
Bidgoli SA; Mahdavi M; Rezayat SM; Korani M; Amani A; Ziarati P
Acta Med Iran; 2013 May; 51(4):203-8. PubMed ID: 23690097
[TBL] [Abstract][Full Text] [Related]
5. A Randomized Controlled Study of Silver-Based Burns Dressing in a Pediatric Emergency Department.
Brown M; Dalziel SR; Herd E; Johnson K; Wong She R; Shepherd M
J Burn Care Res; 2016; 37(4):e340-7. PubMed ID: 26171678
[TBL] [Abstract][Full Text] [Related]
6. Acticoat dressings and major burns: systemic silver absorption.
Moiemen NS; Shale E; Drysdale KJ; Smith G; Wilson YT; Papini R
Burns; 2011 Feb; 37(1):27-35. PubMed ID: 20961690
[TBL] [Abstract][Full Text] [Related]
7. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis.
Huang Y; Li X; Liao Z; Zhang G; Liu Q; Tang J; Peng Y; Liu X; Luo Q
Burns; 2007 Mar; 33(2):161-6. PubMed ID: 17175106
[TBL] [Abstract][Full Text] [Related]
8. Use of Acticoat dressings in burns: what is the evidence?
Khundkar R; Malic C; Burge T
Burns; 2010 Sep; 36(6):751-8. PubMed ID: 20346592
[TBL] [Abstract][Full Text] [Related]
9. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds.
Tredget EE; Shankowsky HA; Groeneveld A; Burrell R
J Burn Care Rehabil; 1998; 19(6):531-7. PubMed ID: 9848045
[TBL] [Abstract][Full Text] [Related]
10. Healing at home: Comparing cohorts of children with medium-sized burns treated as outpatients with in-hospital applied Acticoat to those children treated as inpatients with silver sulfadiazine.
Peters DA; Verchere C
J Burn Care Res; 2006; 27(2):198-201. PubMed ID: 16566565
[TBL] [Abstract][Full Text] [Related]
11. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds.
Muangman P; Chuntrasakul C; Silthram S; Suvanchote S; Benjathanung R; Kittidacha S; Rueksomtawin S
J Med Assoc Thai; 2006 Jul; 89(7):953-8. PubMed ID: 16881426
[TBL] [Abstract][Full Text] [Related]
12. [Multi-center clinical study of acticoat (nanocrystalline silver dressing) for the management of residual burn wounds].
Li XL; Huang YS; Peng YZ; Liao ZJ; Zhang GA; Liu Q; Tang J; Liu XS; Luo QZ
Zhonghua Shao Shang Za Zhi; 2006 Feb; 22(1):15-8. PubMed ID: 16680954
[TBL] [Abstract][Full Text] [Related]
13. The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study.
Innes ME; Umraw N; Fish JS; Gomez M; Cartotto RC
Burns; 2001 Sep; 27(6):621-7. PubMed ID: 11525858
[TBL] [Abstract][Full Text] [Related]
14. Silver absorption on burns after the application of Acticoat: data from pediatric patients and a porcine burn model.
Wang XQ; Kempf M; Mott J; Chang HE; Francis R; Liu PY; Cuttle L; Olszowy H; Kravchuk O; Mill J; Kimble RM
J Burn Care Res; 2009; 30(2):341-8. PubMed ID: 19165102
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the penetration of nanocrystalline silver through various wound dressing mediums: An in vitro study.
Potgieter MD; Meidany P
Burns; 2018 May; 44(3):596-602. PubMed ID: 29290512
[TBL] [Abstract][Full Text] [Related]
16. Transdermal uptake and organ distribution of silver from two different wound dressings in rats after a burn trauma.
Pfurtscheller K; Petnehazy T; Goessler W; Bubalo V; Kamolz LP; Trop M
Wound Repair Regen; 2014; 22(5):654-9. PubMed ID: 25139317
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice.
Supp AP; Neely AN; Supp DM; Warden GD; Boyce ST
J Burn Care Rehabil; 2005; 26(3):238-46. PubMed ID: 15879745
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the antibacterial effect of silver sulfadiazine 1%, mupirocin 2%, Acticoat and octenidine dihydrochloride in a full-thickness rat burn model contaminated with multi drug resistant Acinetobacter baumannii.
Selçuk CT; Durgun M; Ozalp B; Tekin A; Tekin R; Akçay C; Alabalık U
Burns; 2012 Dec; 38(8):1204-9. PubMed ID: 22688192
[TBL] [Abstract][Full Text] [Related]
19. Degree of the hazards of silver-containing dressings on MRSA-infected wounds in Sprague-Dawley and streptozotocin-induced diabetic rats.
Yeo ED; Yoon SA; Oh SR; Choi YS; Lee YK
Wounds; 2015 Apr; 27(4):95-102. PubMed ID: 25855853
[TBL] [Abstract][Full Text] [Related]
20. Nanosilver Dressing in Treating Deep II Degree Burn Wound Infection in Patients with Clinical Studies.
Wu B; Zhang F; Jiang W; Zhao A
Comput Math Methods Med; 2021; 2021():3171547. PubMed ID: 34938352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
